Recalibrating the risks and benefits of lithium therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Summary

Recent data might subtly recalibrate the risk/benefit ratio of lithium, the prototypical mood stabiliser for bipolar disorder. There are hints that lithium might be associated with a reduction in dementia risk and as noted in this Journal, a surprising reduction in the risk of cancer.

Related Topics

    loading  Loading Related Articles